Published in N Engl J Med on November 06, 2012
Protocolized Diuretic Strategy in Cardiorenal Failure (ProDiuS) | NCT01921829
Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA (2013) 4.84
De novo acute heart failure and acutely decompensated chronic heart failure. Dtsch Arztebl Int (2015) 1.93
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. JACC Heart Fail (2014) 1.79
Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial. Circ Heart Fail (2013) 1.21
Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail (2013) 1.19
Renal replacement therapy in acute kidney injury: controversy and consensus. Crit Care (2015) 1.12
Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail (2013) 1.00
Cardiorenal syndrome: pathophysiology and potential targets for clinical management. Nat Rev Nephrol (2012) 0.95
Cardiorenal syndrome: a cardiologist's perspective of pathophysiology. Clin J Am Soc Nephrol (2013) 0.95
Decongestion in acute heart failure. Eur J Heart Fail (2014) 0.94
Cardiorenal syndrome: ultrafiltration therapy for heart failure--trials and tribulations. Clin J Am Soc Nephrol (2013) 0.93
Cardiorenal syndrome: new developments in the understanding and pharmacologic management. Clin J Am Soc Nephrol (2013) 0.91
Renal impairment and worsening of renal function in acute heart failure: can new therapies help? The potential role of serelaxin. Clin Res Cardiol (2015) 0.90
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF. Eur J Heart Fail (2014) 0.90
The kidney in heart failure: an update. Eur Heart J (2015) 0.90
Ultrafiltration in heart failure with cardiorenal syndrome. N Engl J Med (2013) 0.89
Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. J Card Fail (2014) 0.89
Three feasible strategies to minimize kidney injury in 'incipient AKI'. Nat Rev Nephrol (2013) 0.88
Ultrafiltration in heart failure with cardiorenal syndrome. N Engl J Med (2013) 0.87
Ultrafiltration in heart failure with cardiorenal syndrome. N Engl J Med (2013) 0.87
Ultrafiltration in heart failure with cardiorenal syndrome. N Engl J Med (2013) 0.87
Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF). Am Heart J (2015) 0.86
Clinical Use of Diuretics in Heart Failure, Cirrhosis, and Nephrotic Syndrome. Int J Nephrol (2015) 0.86
Influence of age-related versus non-age-related renal dysfunction on survival in patients with left ventricular dysfunction. Am J Cardiol (2013) 0.84
Assessment and prevalence of pulmonary oedema in contemporary acute heart failure trials: a systematic review. Eur J Heart Fail (2015) 0.83
Renal function on admission modifies prognostic impact of diuretics in acute heart failure: a propensity score matched and interaction analysis. Heart Vessels (2016) 0.82
Management of the cardiorenal syndrome in decompensated heart failure. Cardiorenal Med (2014) 0.82
Early management of patients with acute heart failure: state of the art and future directions--a consensus document from the SAEM/HFSA acute heart failure working group. Acad Emerg Med (2014) 0.82
Assessing continuous renal replacement therapy as a rescue strategy in cardiorenal syndrome 1. Clin Kidney J (2014) 0.80
Role of diuretics and ultrafiltration in congestive heart failure. Pharmaceuticals (Basel) (2013) 0.80
Acute heart failure with preserved ejection fraction: unique patient characteristics and targets for therapy. Curr Heart Fail Rep (2013) 0.80
Novel renal biomarkers to assess cardiorenal syndrome. Curr Heart Fail Rep (2014) 0.80
Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure. J Card Fail (2015) 0.80
Reconsidering ultrafiltration in the acute cardiorenal syndrome. N Engl J Med (2012) 0.79
Cardiorenal syndrome type 2: from diagnosis to optimal management. Ther Clin Risk Manag (2014) 0.79
Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload. Case Rep Cardiol (2013) 0.78
Ultrafiltration in patients with decompensated heart failure and diuretic resistance: an Asian centre's experience. Singapore Med J (2016) 0.78
Causes and treatment of oedema in patients with heart failure. Nat Rev Cardiol (2013) 0.78
Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study. PLoS One (2014) 0.78
Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score. J Card Fail (2015) 0.78
Collaboration and entanglement: An actor-network theory analysis of team-based intraprofessional care for patients with advanced heart failure. Soc Sci Med (2016) 0.78
Relevance of Changes in Serum Creatinine During a Heart Failure Trial of Decongestive Strategies: Insights From the DOSE Trial. J Card Fail (2016) 0.78
Renal dysfunction in acute congestive heart failure: a common problem for cardiologists and nephrologists. Heart Fail Rev (2014) 0.78
Current and Potential Therapeutic Strategies for Hemodynamic Cardiorenal Syndrome. Cardiorenal Med (2015) 0.77
Acute decompensated heart failure update. Curr Cardiol Rev (2015) 0.77
Peritoneal dialysis in patients with refractory congestive heart failure: a systematic review. Cardiorenal Med (2015) 0.77
A patient with heart failure and worsening kidney function. Clin J Am Soc Nephrol (2014) 0.77
Cardiorenal Syndrome Type 1: Renal Dysfunction in Acute Decompensated Heart Failure. J Clin Outcomes Manag (2015) 0.77
Overview of progresses in critical care medicine 2012. J Thorac Dis (2013) 0.76
Volume control in treatment-resistant congestive heart failure: role for peritoneal dialysis. Heart Fail Rev (2014) 0.76
Meta-Analysis of Ultrafiltration versus Diuretics Treatment Option for Overload Volume Reduction in Patients with Acute Decompensated Heart Failure. Arq Bras Cardiol (2015) 0.76
Acute kidney injury: quoi de neuf? Ochsner J (2014) 0.76
Management of Patients Admitted with Acute Decompensated Heart Failure. Ochsner J (2015) 0.75
A patient with AKI after cardiac surgery. Clin J Am Soc Nephrol (2014) 0.75
Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). Am J Cardiol (2017) 0.75
Heart failure: Drugs outperform ultrafiltration in acute cardiorenal syndrome. Nat Rev Nephrol (2012) 0.75
Diuretics or ultrafiltration for acute decompensated heart failure and cardiorenal syndrome? Am J Kidney Dis (2013) 0.75
Peritoneal dialysis for chronic cardiorenal syndrome: Lessons learned from ultrafiltration trials. World J Cardiol (2015) 0.75
Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure. JACC Heart Fail (2016) 0.75
Serum Bicarbonate in Acute Heart Failure: Relationship to Treatment Strategies and Clinical Outcomes. J Card Fail (2016) 0.75
Peritoneal ultrafiltration in end-stage chronic heart failure. Clin Kidney J (2015) 0.75
Implications of Using Different Definitions on Outcomes in Worsening Heart Failure. Circ Heart Fail (2016) 0.75
A pharmacogenetic investigation of intravenous furosemide in decompensated heart failure: a meta-analysis of three clinical trials. Pharmacogenomics J (2016) 0.75
Role of Pulsatile Hemodynamics in Acute Heart Failure: Implications for Type 1 Cardiorenal Syndrome. Pulse (Basel) (2013) 0.75
Focus on renal congestion in heart failure. Clin Kidney J (2015) 0.75
Pharmacological and Non-pharmacological Treatment for Decompensated Heart Failure: What Is New? Curr Heart Fail Rep (2017) 0.75
Advances in the Management of Acute Cardiorenal Syndrome in China: Biomarkers for Predicting Development and Outcomes. Kidney Dis (Basel) (2016) 0.75
Decompensated heart failure. Einstein (Sao Paulo) (2013) 0.75
The future of critical care: renal support in 2027. Crit Care (2017) 0.75
Renal subanalysis of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF): the end of nesiritide as a cardiorenal therapeutic? Circulation (2014) 0.75
Response and tolerance to oral vasodilator up-titration after intravenous vasodilator therapy in advanced decompensated heart failure. Eur J Heart Fail (2015) 0.75
Cardiorenal syndrome: introduction. Clin J Am Soc Nephrol (2013) 0.75
Ultrafiltration in heart failure with cardiorenal syndrome. N Engl J Med (2013) 0.75
Decongestion: Diuretics and other therapies for hospitalized heart failure. Indian Heart J (2015) 0.75
Ultrafiltration Therapy for Heart Failure: Balancing Likely Benefits against Possible Risks. Clin J Am Soc Nephrol (2016) 0.75
What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold? Open Heart (2015) 0.75
Challenges in acute heart failure clinical management: optimizing care despite incomplete evidence and imperfect drugs. Crit Pathw Cardiol (2015) 0.75
Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials. J Card Fail (2016) 0.75
A Practical Comprehensive Approach to Management of Acute Decompensated Heart Failure. Curr Cardiol Rev (2016) 0.75
Integration of medical therapy and mechanical circulatory support in the management of acute heart failure. Arch Med Sci (2015) 0.75
Trial data resolve gaps in evidence-based treatment. Nat Rev Cardiol (2013) 0.75
Impact of Ultrafiltration on Serum Sodium Homeostasis and its Clinical Implication in Patients With Acute Heart Failure, Congestion, and Worsening Renal Function. Circ Heart Fail (2017) 0.75
The role of peritoneal ultrafiltration in the treatment of refractory congestive heart failure. JRSM Open (2015) 0.75
Evidence of Mild Liver Dysfunction Identifies Stable Heart Failure Outpatients with Reversible Renal Dysfunction. Cardiorenal Med (2015) 0.75
Cardio-renal syndrome. F1000Res (2016) 0.75
Heart failure. Drugs outperform ultrafiltration in acute cardiorenal syndrome. Nat Rev Cardiol (2012) 0.75
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure. Korean Circ J (2017) 0.75
Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence. Dis Markers (2017) 0.75
Effects of hypertonic saline solution on body weight and serum creatinine in patients with acute decompensated heart failure. World J Cardiol (2017) 0.75
Extracorporeal Ultrafiltration for Fluid Overload in Heart Failure: Current Status and Prospects for Further Research. J Am Coll Cardiol (2017) 0.75
Defining the role of ultrafiltration therapy in acute heart failure: a systematic review and meta-analysis. Heart Fail Rev (2016) 0.75
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med (2011) 7.62
Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol (2007) 6.12
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
Potential effects of aggressive decongestion during the treatment of decompensated heart failure on renal function and survival. Circulation (2010) 3.78
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J (2004) 3.37
Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med (2010) 2.71
Diuretics and ultrafiltration in acute decompensated heart failure. J Am Coll Cardiol (2012) 2.32
Is worsening renal function an ominous prognostic sign in patients with acute heart failure? The role of congestion and its interaction with renal function. Circ Heart Fail (2011) 2.28
Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. J Am Coll Cardiol (2005) 1.99
Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol (2012) 1.90
Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients. J Card Fail (2006) 1.49
Cardiorenal rescue study in acute decompensated heart failure: rationale and design of CARRESS-HF, for the Heart Failure Clinical Research Network. J Card Fail (2012) 1.43
Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol (2001) 1.40
Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics. Am J Kidney Dis (2011) 1.26
Treatment of congestion in congestive heart failure: ultrafiltration is the only rational initial treatment of volume overload in decompensated heart failure. Circ Heart Fail (2009) 1.23
Ultrafiltration for cardiorenal syndrome. J Card Fail (2008) 1.12
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med (2005) 27.36
Bariatric surgery: a systematic review and meta-analysis. JAMA (2004) 23.34
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med (2004) 19.42
Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med (2007) 17.85
Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med (2015) 13.90
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
Angiotensin-neprilysin inhibition versus enalapril in heart failure. N Engl J Med (2014) 11.77
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med (2008) 11.61
Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med (2013) 11.34
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med (2003) 10.57
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med (2011) 10.29
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA (2004) 9.74
Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med (2004) 9.67
C-reactive protein levels and outcomes after statin therapy. N Engl J Med (2005) 9.47
Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med (2008) 9.25
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med (2004) 9.13
Trends in heart failure incidence and survival in a community-based population. JAMA (2004) 8.90
Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med (2006) 8.74
Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med (2015) 8.70
Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med (2015) 8.69
Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med (2010) 8.28
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA (2011) 8.24
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med (2009) 7.71
Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2013) 7.70
Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA (2005) 7.41
Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. N Engl J Med (2005) 6.86
Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA (2005) 6.81
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial. Lancet (2012) 6.69
Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med (2011) 6.65
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med (2012) 6.51
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial. Lancet (2012) 6.42
Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA (2003) 6.39
HFSA 2010 Comprehensive Heart Failure Practice Guideline. J Card Fail (2010) 6.37
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA (2009) 6.36
Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med (2008) 6.17
Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. JAMA (2005) 6.10
Systolic and diastolic heart failure in the community. JAMA (2006) 5.99
A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med (2009) 5.81
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med (2012) 5.33
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA (2013) 5.31
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med (2005) 5.28
Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med (2008) 5.13
Non-evidence-based ICD implantations in the United States. JAMA (2011) 5.05
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05